05/20/2025 7:58 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2025 5:14 PM | BioNTech (Subject) Medine GmbH (Filed by)
| Form SCHEDULE 13G/A | |
05/07/2025 6:30 AM | BioNTech (Subject) Jeggle Helmut Wolfgang (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2025 6:33 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/05/2025 5:53 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/05/2025 5:33 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2025 6:54 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/10/2025 5:57 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/10/2025 6:00 AM | BioNTech (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
02/27/2025 6:57 AM | BioNTech (Subject) Richardson Ryan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2025 6:53 AM | BioNTech (Subject) Medine GmbH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for BNTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioNTech and its competitors with MarketBeat's FREE daily newsletter.
|
02/20/2025 6:50 AM | BioNTech (Subject) Poetting Sierk (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025 6:02 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/14/2025 5:58 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2024 6:25 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2024 6:21 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/13/2024 4:56 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024 4:25 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/09/2024 5:35 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024 4:57 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024 4:50 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024 5:37 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024 4:06 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024 6:38 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024 5:49 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024 5:53 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024 5:57 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/18/2024 8:04 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2024 4:03 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024 7:41 AM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2024 3:15 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024 3:13 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024 3:24 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2024 3:17 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024 4:14 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024 5:18 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/01/2024 7:12 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024 3:52 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 4:12 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2024 6:14 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024 8:17 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad) Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade.
In 2023, it surged 239%. And in 2024, it soared another 171% on the year…
But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less? Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. |
09/18/2024 6:28 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 4:35 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024 7:53 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/22/2024 3:31 PM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/19/2024 7:34 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/16/2024 5:56 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/05/2024 5:32 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/05/2024 5:34 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2024 8:08 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/24/2024 7:07 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2024 6:18 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2024 6:46 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024 3:36 PM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |